Featured Content

Planning for proactive pharmacovigilance

Friday, September 1, 2017

The role of pharmacovigilance is becoming increasingly prominent, with scope to inform product strategy and health economics. A recent industry debate hosted by ProductLife Group saw some interesting tips for clinical operations.

[Read More]

Implementing end-to-end trial technology solutions

Friday, September 1, 2017

While innovation in clinical trial technology can vastly improve processes and workflows, these technologies often create new challenges for sponsors and CROs—especially when the technologies are not compatible. The innovations are so diverse that sponsors and CROs have difficulty implementing comprehensive solutions. Interoperability is now more critical than ever.

[Read More]

Walgreens to promote ongoing outcomes studies beneficial in clinical research

Monday, August 28, 2017

In a move that mirrors longstanding practices in the pharma clinical trial research arena, Walgreens is making a case for partnerships between clinical researchers and a retail pharmacy provider. This month the company announced the creation of its Center for Health & Wellbeing Research (CHWB) website that will initially showcase 50 “outcomes studies” the company has completed over the past six years.

[Read More]

New EU medical device regulations cause industry shake up

Monday, August 21, 2017

Medical device manufacturers will need to provide substantially more clinical evidence to support claims of safety and performance for many medical and in vitro diagnostic (IVD) devices marketed in the European Union (EU) as the result of two new regulations adopted by the European Parliament.

[Read More]

High costs and recruitment issues drive the globalization of clinical trials

Monday, August 21, 2017

The pursuit of global trials is increasing. A report by SCORR Marketing and Applied Clinical Trials examined the reasons why companies are pursuing global clinical trials and the challenges they face in conducting them. The top two reasons cited in the survey for trials exiting the U.S. and Western Europe and moving to other regions were high costs and  patient recruitment difficulty.

[Read More]

BRANY protocol launch showcases paradigm shift in behavioral and social sciences research

Thursday, August 17, 2017

Biomedical Research Alliance of New York (BRANY) released a new research protocol template specifically designed to address the unique needs of social-behavioral-educational researchers. This launch comes as part of Protocol Builder, a secure, cloud-based protocol writing application. This special template provides a guided, step-by-step protocol-writing process for investigators who specialize in psychology, nursing, education and other disciplines that are focused on behavioral and social functioning.

[Read More]